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Summary 
Murine mammary tumor viruses (MMTVs) are retroviruses that encode superantigens capable 
of stimulating T cells via superantigen-reactive T cell receptor Vfl chains. MMTVs are transmitted 
to the suckling offspring through milk. Here we show that B cell-deficient mice foster nursed 
by virus-secreting mice do not transfer infectious MMTVs to their offspring. No MMTV proviruses 
could be detected in the spleen and mammary tissue of these mice, and no deletion of MMTV 
superantigen-reactive T  cells occurred. By contrast, T  cell deletion and positive selection due 
to endogenous MMTV  superantigens occurred in B cell-deficient mice. We conclude that B 
cells are essential for the completion of the viral life cycle in vivo, but that endogenous MMTV 
superantigens can be presented by cell types other than B cells. 
M 
urine mammary tumor viruses (MMTVs) 1 are infec- 
tious retroviruses transmitted through milk from the 
mother to  newborns.  The virus infects lymphocytes after 
passing through the gut epithelium of the pups and is then 
transmitted from the lymphocytes to the mammary tissue, 
where it replicates and is secreted into the milk (1-3). MMTVs 
encode superantigens,  which stimulate T  cells  expressing 
superantigen-reactive TCR V3 chains. The superantigen is 
encoded by the MMTV sag gene in the U3 region of the 
3' LTR (4,  5).  MMTV(C3H),  carried by the mouse strain 
C3H/He, encodes a superantigen that stimulates V~14 + T 
cells, whereas the superantigen of another MMTV used in 
this study, MMTV(SW),  stimulates V~6 + T  cells  (6,  7). 
MMTV(SW) is of special interest, because its superantigen 
is virtually identical to Mls-1, the prototype of endogenous 
superantigens encoded by Mtv-7  (8,  9). 
Endogenous MMTVs are derived from rare infections of 
germ line cells, leading to Mendelian inheritance of the provirus 
(10).  About  45  different endogenous  MMTVs  have been 
identified in inbred and wild mice (1). Most of them no longer 
produce infectious virus particles (11). On the other hand, 
most if not all of these proviruses have an open reading frame 
in the U3 region, which encodes polymorphic superantigens. 
These endogenous MMTV superantigens lead to deletion of 
T cells expressing the appropriate TCR V~/genes by virtue 
1 Abbreviation used in this paper: MMTV, murine mammary  tumor virus. 
of self-tolerance induction during thymic development. For 
instance, Mls-1, the superantigen encoded by Mtv-7 sag, leads 
to deletion of V36 +, 7 + , 8.1 +, and 9 + T  cells (12-16).  In 
addition, Mls-1 causes positive selection of V314 + T  cells 
(17). Superantigens encoded by infectious MMTVs also in- 
duce clonal deletion, but the deletion process begins later 
in the development of the mouse and occurs at a slower rate 
compared with superantigens encoded by endogenous MMTVs 
(7, 18, 19). Experimental evidence indicates that superantigen- 
mediated stimulation of T cells is essential for transmission 
of infectious MMTV, because mice specifically lacking super- 
antigen-reactive T  cells do not transmit the virus (20-22). 
Although it has been known for a long time that B cells 
express  endogenous MMTV superantigens (23),  their role 
in viral transmission was only addressed recently. Held et al. 
(21, 22) demonstrated that MMTVs primarily infect B cells, 
and that activated B cells show the highest level of MMTV 
proviral infection. Furthermore, they found that viral infec- 
tion leads to specific activation and proliferation of B cells. 
In this study we investigated whether B cells are essential 
for MMTV infection in mice deficient in B cells because of 
disruption of one of the membrane exons of the IgM H chain 
gene (24). We tested these mice for their capacity to transmit 
infectious MMTVs and delete T  cells due to superantigen 
expression by infectious as well as endogenous MMTVs. 
We found neither deletion of T cells reactive to infectious 
MMTV superantigens nor proviral insertions in spleen and 
mammary tissue of B cell-deficient mice that had been foster 
nursed by MMTV-secreting mothers.  However, in foster- 
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in  these  tissues.  Furthermore,  heterozygous offspring  of 
MMTV-infected B cell-deficient mice showed no detectable 
signs  of viral infection.  We conclude that  MMTVs,  after 
passing through the gut epithelium, infect B cells, and that 
infection of T  cells is dependent on the presence of B cells. 
The infection of B cells is a crucial step in the viral life cycle, 
because no MMTV proviruses were detectable in the mam- 
mary tissue of B cell-deficient mice, and no viral transmis- 
sion to the offspring of these mice occurred. 
On the other hand, negative and positive selection of T 
cells due to superantigens encoded by endogenous MMTVs 
was as efficient in B cell-deficient as in control mice. These 
results indicate that presentation of endogenous superantigens 
can occur by cell types other than B  cells. 
Materials  and Methods 
Mice.  All mice used in this study were bred and maintained 
at the animal facility of Tufts University School of Medicine. One 
male homozygous #MT mouse (24), backcrossed several genera- 
tions with C57BL/6, was crossed with a female AKR/J mouse 
(The Jackson Laboratories, Bar Harbor, ME). The F1 generation 
was intercrossed, and the F~ and F3 generations were typed for en- 
dogenous MMTV, MHC class II, and the mutated  C# gene by 
use of  Southern blot analysis. C3H/HeOu, C57BL/6, and CBA/Ca 
strains were obtained  from The Jackson  Laboratories, and  the 
BALB/c SW mice (7) were kindly provided by Dr. H. Acha-Orbea 
(Ludwig Institute, Lausanne, Switzerland). For the foster-breeding 
experiments, offspring ~<3 d were removed from their parents and 
nursed by C3H/HeOu or BALB/c SW mothers  that had given 
birth within the last 3 d. The litter of the nursing mother was 
removed with the exception of two or three pups, which served 
as control animals for successful MMTV transmission. 
Southern Blot Analysis.  DNA was extracted from tail tissue of 
mice, as described (25), and 10 #g DNA was digested with 20 U 
of PvulI (New England Biolabs, Beverly,  MA). Southern blots were 
carried out as previously described (26), except that denaturation 
was carried out in 0.2 M NaOH, 0.75 M NaC1. For MMTV typing, 
blots were hybridized with an MMTV-LTR-specific probe (27); 
a 2.2-kb band was indicative for Mtv-7 (9). For typing the disrupted 
C# gene, a BgllI-PstI fragment from IgM H chain cDNA (28) 
was used as probe; an •3.3-kb  band corresponded to the disrupted 
C# gene, and an "~3.2-kb band corresponded to the wild-type C# 
gene. DNA derived from a heterozygous animal was run on all 
blots as a control. An EcoRI-XhoI fragment,  derived from the 
genomic clone of the I-A~ gene, was used as a probe for MHC 
class II typing (29). This probe hybridizes to an *3.7-kb band for 
I-A  b and an '~4.4-kb  band for I-A  k. 
Antibodies.  The following antibody-producing  hybridomas were 
obtained from the American Type  Culture Collection (Rockville, 
MD):  anti-Vt86 (44-22-1)  and  anti-V~8.2  (F23.2). Anti-VB5 
(MR9-4)  and  anti-V/511 (RR3-15)  (30,  31)  hybridomas  were 
provided by Dr. S. Datta and anti-B220 (RA3-6B2) (32) hybrid- 
omas were provided by Dr. H. Wortis (Tufts University, Boston, 
MA). mAbs were biotinylated after purification from tissue cul- 
ture supematant using protein A-Sepharose  beads. Biotinylated  anti- 
V/~8.1-8.2 (KJ16) and anti-V/314 (14-2) mAb were purchased from 
PharMingen (San Diego, CA). The anti-CD4  (GK1,5) and anti- 
CD8 (Tib 105) mAbs were also obtained from the American Type 
Culture Collection and were used in FITC (Sigma Chemical Co., 
St. Louis, MO) conjugated form. 
Flow Cytometry.  Single-cell  suspensions were prepared from 
spleen and thymus of 5- and 10-d-old mice, and the spleen cell sus- 
pension was treated with Tris-buffered ammonium chloride to lyse 
red blood cells. Whole blood (0.5 ml) was obtained from individual 
mice, and PBMC were purified on a gradient  (9.9%  Ficoll 400; 
Sigma Chemical Co.), 9.6% sodium metrizoate (Accurate Chem- 
ical and Scientific Corp., Westbury, NY)). The cells were washed 
in HBSS (Gibco BRL, Gaithersburg, MD), incubated on ice for 
30 min  with the biotinylated  anti-V3  or anti-B220 antibodies, 
washed again, and incubated for another 30 min with the FITC- 
conjugated anti-CD4 or anti-CD8 antibodies and with PE-strep- 
tavidin (Southern Biotechnology Associates, Inc.,  Birmingham, 
AL).  Two-color fluorescence cytometry was carried out with a 
flow cytometer (FACScan|  Becton Dickinson & Co., Mountain 
View, CA). 
MMTV-C3H Provirus Assay.  DNA was prepared from spleen 
or mammary tissue according to published procedures (25). The 
MMTV(C3H) LTR sequence was amplified from 5 #g DNA with 
PCR in PCR buffer (Perkin Elmer Corp., Norwalk,  CT), 1 mM 
each dATP, dCTP, dGTP, and dTTP, 1 #M each primer, and 2.5 U 
AmpliTaq DNA polymerase (Perkin-Elmer) in a final volume of 
50  #1  (5'  primer:  CTCTTACAAGCCGCATCGAT;  Yprimer: 
TAATGTTCTATTAGTCCAGCCACTGT).  Amplification  was car- 
tied out in a DNA thermal cycler  (Perkin-Elmer)  with the following 
program: 19 cycles of 1 min at 94~  2 rain at 550C, and 2 rain 
at 72~  16 cycles of 1 min at 94~  2 min at 55~  and 2-4.5 
min at 72~  finished by 10 min at 72~  and cooling down to 
4~  20 #I reaction mixture was digested with 1 U MunI (Strata- 
gene Inc., La Jolla, CA) for 1 h at 37~  500 ng ScaI-digested 
pSV2cat plasmid was added before the digest; this served as an in- 
ternal control for a successful restriction enzyme digest. ScaI-cut 
pSV2cat yields two bands at 1.4 and 0.8 kb after digestion with 
MunI. 20 #1 undigested DNA was run next to the digested DNA 
on a 1% agarose gel (MetaPhor; FMC Corp., Rockland, ME) in 
1 x  TBE. Bands were visualized by staining with ethidium bro- 
mide. For Southern blotting, the gel was denatured in 0.4 M NaOH, 
1.5 M NaC1 for 30 rain, neutralized for 30 min in 1 M NaC1, 1.5 M 
Tris-HCl, pH 8.0 (all Sigma Chemical Co.), and soaked for 20 rain 
in 1  x  TAE. DNA was transferred to a nylon membrane (Bio- 
trans; ICN Biomedicals, Inc., Irvine, CA) in 1 x  TAE with The 
Panther  TM  Semi-Dry Electroblotter  (Owl Scientific Inc.,  Cam- 
bridge, MA) for 1 h at 295 mA. The membrane was UV cross- 
linked and treated as described in Southern blot analysis. A 374-bp 
RsaI fragment of the MMTV(C3H) LTR (27) was used as probe. 
Results 
Establishment  of  H-2  k Mtv-7 + B  Cell-Deficient Mic~  #MT 
mice are deficient in B cells because of the disruption of one 
of the membrane exons of the IgM H chain gene (24). They 
were derived from 129/Sv and were subsequently backcrossed 
to C57BL/6, two mouse strains that are H-2  b and Mtv-7-. 
Because  mice of the H-2  b MHC haplotype do not express 
MHC I-E molecules, most MMTV  superantigens are not 
presented. Thus, the #MT mice were crossed with AKR/J 
mice,  which  are H-2  k,  an  MHC  haplotype that  presents 
MMTV superantigens very efficiently (13, 14). In addition, 
AKR/J mice are Mtv-7 +  , allowing us to study the presen- 
tation of the endogenous superantigen Mls-1 in B ceU-deficient 
mice.  F2-  and  F3-generation mice derived from this  cross 
were used for aU the studies described in this  article.  The 
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and Mtv-7 by Southern blotting, 
B Cell-deficient Mice Infected with MMTV(C3H) Do Not De- 
lete  V~14 +  CD4 +  T  Cells.  It  has  been  suggested  that 
MMTV infection occurs first in B cells and only later in T 
cells (21,  22).  To test,  therefore, whether mice deficient in 
B cells are protected from viral infection, we foster nursed 
B cell-deficient mice on C3H/HeOu females, which secrete 
MMTV(C3H). MMTV(C3H) encodes a superantigen leading 
to the deletion of V314 §  CD4 + T  cells (4,  5)  (i.e.,  a de- 
crease in V314 + T  cells is indicative of a successful MMTV 
[C3H]  infection).  As  shown  in  Fig.  1 A,  no  deletion of 
VB14 + CD4 + T  cells could be observed in  the B  cell-de- 
ficient  mice,  whereas  heterozygous  B  cell-mutant  and 
C3H/HeOu  mice, which were foster nursed together with 
the B cell-deficient mice, showed deletion of V314 + CD4 + 
T  cells.  The higher percentage of VB14 + CD4 §  T  cells in 
heterozygous B cell-mutant mice compared with C3H/HeOu 
mice could be due to the reduced number of B cells in the 
heterozygous B  cell-mutant  mice,  as well as to  strain  dif- 
ferences. 
We also infected B cell-deficient mice with another virus, 
MMTV(SW)  (7).  The MMTV(SW)  superantigen  is very 
similar to Mls-1, and, like Mls-1, leads to deletion of V/~6 § 
T  cells.  Mtv-7-,  H-2  k  B  cell-deficient  mice  were  foster 
nursed by BALB/c SW  mice,  which  secrete MMTV(SW) 
in the milk.  No deletion of superantigen-reactive V~6 + T 
cells was observed in B cell-deficient mice, whereas deletion 
was already detectable after 6 wk in the heterozygous litter- 
mates of the same offspring and the control BALB/c mice, 
nursed together with  the B  cell-deficient mice (Fig.  1 B). 
At 6 mo of age, the infected heterozygous animals had most 
of their  VB6 §  T  cells  deleted,  whereas  in  the B  cell-de- 
ficient mice,  the  amount  of V/36 §  T  cells was  still  com- 
parable to  the noninfected animals. 
Although  these  results  support  the  hypothesis  that  B 
cell-deficient mice are resistant to MMTV infection, it is con- 
ceivable that these mice were actually infected, but the lack 
of B cells prevented the presentation of the MMTV-encoded 
superantigens and, thus, prevented the deletion of the appro- 
priate T  cells. To address this issue, we determined whether 
spleen cells and the mammary tissue of these mice were infected 
with MMTV(C3H),  with proviral insertion as a read-out. 
B Cell-deficient  Mice Have No Detectable Proviral Insertions 
in Spleen Cells or Mammary Tissue.  It is difficult to distin- 
guish MMTV(C3H)  proviruses from endogenous MMTVs 
by conventional Southern blot or PCI~ techniques, because 
the DNA sequences are closely related (33). Thus, we devel- 
oped a sensitive and specific assay for MMTV(C3H) proviruses, 
using a MunI restriction enzyme site that is unique for the 
MMTV(C3H)  LTR (position 521 in Brandt-Carlson  et al. 
[33]). Among the sequenced endogenous MMTV LTRs, only 
the Mtv-2 LTR contains a MunI site; however, Mtv-2 is not 
present in mice used in this study. We designed PCI~ primers 
homologous to the MMTV(C3H) LTP,. sequences that should 
preferentially amplify these sequences, although the primers 
are not specific enough to prevent amplification of endoge- 
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Figure  1.  MMTV-infected  B cell-deficient mice do not delete T cells 
reactive with viral superantigen. (A) Percentage  of V314 + CD4 + T cells 
determined by flow cytometry in peripheral blood of 4-too-old mice in- 
fected  with MMTV(C3H). First bar represents results from a noninfected, 
heterozygous  B cell-mutant mouse (#Mt/+). The remaining bars are the 
results from MMTV(C3H)-infected animals. C3H; C3H/HeOu mice 
foster-nursed together with B call-mutant mice (control mice for successful 
infection); l~Mt/+, heterozygous B  cell-mutant  mice; #MT/IzMT, 
homozygous B cell-deficient mice. Single result for a non-foster-nursed 
animal was obtained from an age-matched animal in the same FACS ex- 
periment. Percentage  of V~14 + T cells in various noninfected/zMT mice 
are also shown in Fig. 7. (/3) Percentage of V36 + CD4 + T cells in pe- 
ripheral blood of 6-wk- (grey bars) and 6-too- (hatched bars) old mice in- 
fected  with MMTV (SW). First three bars show representative  results from 
noninfected animals for comparison; percentages of V36 + CD4 + T cells 
of more uninfected/~MT mice are shown in Fig. 4. The remaining bars 
represent results from animals infected with MMTV (SW). BALB/cSW, 
offspring  foster-nursed  together with B cell-mutant mice. Results for each 
figure were obtained from two independent litters. Numbers in parenthesis 
represent number of animals tested. Error bars show SD. 
nous  MMTV  LTR  sequences.  The  amplified  DNA  was 
digested with MunI, yielding two fragments of 400 and 200 
bp specific for the MMTV(C3H) LTR. Spleen cells have been 
shown  to contain MMTV  proviruses in infected mice (2). 
Therefore, spleen DNA from C3H/HeOu mice, which carry 
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spleen and mammary tissue of infected  B cell-deficient  mice. 
MMTV(C3H) provirus-specific  PCR was performed as de- 
scribed in Materials and Methods, and DNA samples were 
run on an agarose gel and stained with ethidium bromide; 
Southern blotting was performed  with some of the gels, but 
no additional bands were revealed. Each sample was loaded 
undigested (MunI-) and digested  with MunI (MunI +  ) to in- 
dicate specificity  of the digest. PCR yields a specific  band of 
600 bp derived  from the MMTV(C3H) provirus and endog- 
enous MMTV (endo). Another band (x) was observed  in most 
samples, however,  this band seems  to be the result  of  nonspecific 
amplification, because an MMTV LTR probe does not hy- 
bridize with  this band. MunI  digestion yields the  two 
MMTV(C3H)-specific  bands at 200 and 400 bp (C3H). (A) 
Lane 1 shows the results with DNA from a freshly isolated 
C3H/HeOu mammary tumor as template. Spleen  DNA was 
used as template  in lanes  2-8. DNA was obtained  from  a nonin- 
fected B cell-deficient mouse (lane 2),  a heterozygous B 
cell-mutant mouse foster-nursed  by C3H/HeOu (lane  3), a 
C3H/HeOu mouse (lane 5) and four B cell-deficient  mice 
(lanes 4 and 6-8) derived from three different litters. Lane 
9 shows no DNA control. Lane 10, 100-bp marker (Gibco 
BRL). All results shown were obtained in the same PCR ex- 
periment. (B) MMTV(C3H) provirus assay performed  with 
mammary tissue DNA. First two samples were derived  from 
heterozygous  B-mutant mice, other two samples  were  derived 
from B cell-deficient mice. Southern blotting  revealed no 
MMTV(C3H)-specific bands in B cell-deficient mice. 
MMTV(C3H),  was tested with this assay,  and the expected 
400-  and  200-bp bands  were observed after digestion with 
MunI  (Fig. 2 A, lane 5). To exclude the possibility that en- 
dogenous  MMTVs  with  LTR  sequences  similar  to  the 
MMTV(C3H)  LTR cause  false positive  results,  we  tested 
DNAs from various MMTV(C3H)-free B cell-mutant mice 
containing  a variety of endogenous  MMTVs.  None of the 
PCR-amplified fragments was cut by MunI, indicating that 
the assay is specific for MMTV(C3H) proviruses (results not 
shown). By diluting DNA from a mammary tumor (approx- 
imately one proviral copy per cell) with DNA  from mam- 
mary tissue of a noninfected mouse, we estimated that this 
assay is  sensitive enough  to  detect  one infected cell in  104 
cells by ethidium bromide staining and at least one infected 
cell in  106 cells by Southern blotting,  respectively. 
Using this assay, we tested spleen DNA from B cell-deficient 
mice that had been foster nursed by C3H/HeOu  mice and 
had  been  analyzed  for  their  level  of V~/14 +  T  cells.  No 
MMTV(C3H)  proviral  infections could be detected in  the 
B cell-deficient mice, whereas the heterozygous controls and 
C3H/HeOu  mice clearly showed  the presence of MMTV- 
(C3H) proviruses in spleen cells (Fig.  2 A).  We also tested 
DNA  from the mammary tissue of these mice for proviral 
infection, because this tissue shows the highest level of viral 
infection and is the site of viral transmission to the offspring 
(2).  Again,  we could not  detect  any proviral insertions  in 
homozygous  mutant  mice,  but  heterozygous control mice 
were clearly positive (Fig. 2 B). From these results we con- 
clude that B cells are required for MMTV infection of lym- 
phocytes and  mammary  tissue. 
B Cell-deficient Mice Do Not ~ansmit MMTV to the Offspring, 
The above results indicate that infection of mammary tissue 
is inhibited in the absence of B cells.  It may be possible, how- 
ever, that infection of the mammary tissue occurred at a low 
level, undetectable with the method used but still sufhcient 
for transmission of the virus to the offspring. Thus, we bred 
female B cell-deficient mice that had been foster nursed on 
a C3H/HeOu mouse with heterozygous B cell-mutant mice 
and tested the heterozygous offspring of this cross for signs 
of viral infection.  We used heterozygous offspring because 
viral infection is not detectable in homozygous B cell-mu- 
tant mice, as shown above. We analyzed the level of VB14 + 
CD4 + T  cells in these mice and found no deletion of these 
cells.  In addition,  no proviral insertions were detectable in 
the mammary tissue of these animals (Fig. 3). As a control, 
we tested the age-matched  offspring of a  female heterozy- 
gous  B  cell-mutant  mouse that  had been foster nursed by 
a C3H/HeOu  mouse and  found T  cell deletion in the pe- 
riphery and proviral insertions in the mammary tissue. From 
these results we conclude that B cells are essential for viral 
transmission  from  the gut  to  the mammary  tissue. 
B  Cells Are Not Required for Presentation of Mtv-7 or Mtv-9 
Superantigens in vivo.  Having established that B cells are re- 
quired for MMTV infection of newborn mice, it seemed pos- 
sible that B cells may also be responsible for presentation of 
superantigens encoded by endogenous MMTVs, causing de- 
letion of reactive T  cells.  Thus,  we analyzed the TCR VB 
profile of Mtv-7 + B cell-deficient mice. The lack of B cells, 
surmised from the Southern blot typing, was confirmed by 
flow cytometry with  a  B220-specific mAb  and  determina- 
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Figure  4.  B cells are not required for Mls-l-induced clonal deletion 
of V~6 § T cells. Percentage of VB6 + CD4 + T cells (solid bars, left scale) 
and percentage of B220 + cells (grey bars, right scale) in the peripheral blood 
were determined by flow cytometry. The number of mice tested is shown 
in parentheses.  The  first  two pairs  of columns show  the results from 
Mtv-7 + and Mtv-7-  mice, which are heterozygous for the disrupted C/~ 
gene (i.e., they possess B cells), and the second two pairs show the results 
of B cell-deficient mice. The mice were either H-2  k or H-2  b/k, and blood 
samples were taken between 6 wk and 5 mo of age. Age and MHC haplo- 
type did not significantly influence  the level of V~6 + T  cells. The av- 
erage of B220 + cells in the B cell-deficient mice was 0.4  _+  0.2%. 
Figure  3.  B cell-deficient mice do not transmit MMTV to the offspring. 
C3H/HeOu foster-nursed  female B cell-deficient  mice were crossed with 
heterozygous male B cell-mutant mice and the heterozygous offspring 
tested for MMTV(C3H) infection. As a control, we used the heterozy- 
gous offspring from a C3H/HeOu foster-nursed female heterozygous B 
cell-mutant mouse bred with a male B cell-deficient mouse. (.4) Percentage 
of V~/14 +  CD4 + T cells in the peripheral blood of 7-wk-old mice, deter- 
mined by flow  cytometry. Left bar  represents  result from the control 
breeding, other bars show the results from four individual mice of the 
test breeding. (B) Southern blot of MMTV(C3H)  provirus PCK assay 
of these mice (for details of assay see Fig. 2 and Materials and Methods). 
DNA from the mammary tissue of 3-mo-old mice was used as template. 
First four lanes show results from control mice (a noninfected heterozy- 
gous B cell-mutant mouse and the infected heterozygous offspring of the 
control breeding). 
tion of the serum Ig titer.  In all cases, homozygous mutant 
mice  had  no  significant  number  of B220 +  cells  (~0.4  - 
0.18%,  Fig. 4) and undetectable levels of serum Ig (data not 
shown), whereas heterozygous mutant mice had intermediate 
levels  compared  with  control  mice.  We  observed  that 
Mtv-7 +  B  cell-deficient mice  deleted V/36 +  CD4 +  T  cells 
as efficiently as the Mtv-7 + heterozygous litterrnates (Fig. 4). 
The  slightly higher  percentage  of V/36 +  CD4 +  T  cells in 
the  B  cell-deficient mice is not  significant  and  is probably 
due to experimental variation seen in noninbred mouse strains. 
Furthermore, we tested T  cell deletion induced by the Mtv-9 
sag  gene product.  This  superantigen,  also known  as Etc-1, 
deletes V~5 §  and V~11 +  T  cells in vivo,  although  the  ki- 
netics  for  deletion  are  slower  than  for  deletion  by  Mls-1 
(34-36).  Another difference is the inability of the Mtv-9  su- 
perantigen to stimulate naive T  cells in vitro, whereas Mls-1 
is a strong stimulator ofT  cells in vitro (37). Thus, the Mtv-9 
superantigen is considered a weaker superantigen than Mtv-7. 
Fig. 5  shows that deletion of Mtv-9  superantigen-reactive T 
cells was  not impaired in the Mtv-9 +  B  cell-deficient mice, 
similar to the result we obtained for Mls-1.  C57BL/6  mice 
were  used  as  negative control  animals  because  they do not 
VI35  +  CD8 +  T  cells 
V[31 1 +  CD4 +  T  cells 
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csmt~  csA~a  .Mr/+  #MT4awr 
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Figure  5.  B cells are not required for Mtv-9 superantigen-induced T 
cell deletion. Percentage of V~5 + CD8 + T cells (grey bars) and percentage 
of VB11 + CD4 + T cells (black bars) (-+SD) in peripheral blood from mice 
/>6 wk old were determined by flow cytometry. Number of mice tested 
is shown in parentheses.  C57BL/6,  CBA/Ca, heterozygous B cell-mu- 
tant (gMT/+)  and -deficient mice (p.MT/I~MT)  were tested. All these 
mice are Mtv-9 + and H-2  k, except C57BL/6,  which is H-2  b. The H-2b 
haplotype lacks I-E expression, thus no T cell deletion due to Mtv-9 super- 
antigen occurs. 
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of MHC  class II I-E molecules (35,  36).  These results indi- 
cate that the T  cell deletion process due to endogenous  su- 
perantigens in vivo is not influenced by the absence of  B cells, 
regardless of the "antigenic strength" of the particular super- 
antigen. 
T  Cell Deletion Kinetics  in Mtv-7 + B  Cell-Deficient  Mice. 
Although the absence orb cells had no influence on the dele- 
tion of V36 + T  cells in adult Mtv-7 + mice, it was of interest 
to test whether  a  difference could be observed during  on- 
togeny.  If superantigen  presentation  is  less  efficient  in  B 
cell-deficient mice than in heterozygous B cell-mutant mice, 
we would expect slower deletion kinetics in the former mice. 
Thus,  we compared the percentage of V36 + T  cells in the 
spleen  and  thymus  of 5-  and  10-d-old Mtv-7 + hetero-  and 
homozygous  B  cell-deficient  mice.  As can be seen in  Fig. 
6,  5-d-old  B  cell-deficient  mice  deleted  V/36 +  T  cells, 
whereas  the  heterozygous  controls  still  had  high  levels of 
V36 + T  cells.  At day 10 the percentage of V36 + T  cells was 
virtually identical in homo- and heterozygous B cell-deficient 
mice. We observed in all mice that deletion occurred earlier 
in the thymus than in the spleen. These results indicate that 
T  cell deletion due to endogenous superantigens is even more 
efficient in homozygous B-ceU deficient mice than in hetero- 
zygous control mice, especially at early stages of ontogeny. 
Positive Selection of V~14 + T  Cells in Mtv-7 + Mice Is Not 
Affected by the Lack of B  Cells.  It has recently been reported 
that the percentage of V~14 + T  cells is specifically increased 
in  Mls-1 +  mice  (17).  In  the  following  experiments,  we 
tested whether  the lack of B cells has any influence on this 
effect. PBL from H-2  k Mtv-7 §  hetero-  and  homozygous 
B cell-deficient mice were double stained for TCR V314 or 
V38.2 chains (control) and for CD4 and CD8, respectively 
(Fig.  7).  Similar to the results of Liao and Raulet  (17),  we 
detected  a  significant  increase in  V~14 §  CD8 +  T  cells in 
MW-7 + mice compared with Mtv-7-  mice (~50%),  whereas 
12% 
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8% 
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0% 
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Figure 7.  Positive selection of V314 + CD8 + T cells in Mtw7 + mice. 
Blood from 2-3 too-old H-2~ mice was analyzed for V~14+ (top) and 
V~8.2 + (bottom) T cells by flow cytometry. CD4 + T cells are represented 
by grey bars, CD8 + T cells by black bars. The number of animals tested 
is indicated in parentheses. Results are from (left to right) Mtv-7-  hetero- 
zygous B cell-mutant mice, Mtv-7- homozygous, Mtv-7 + heterozygous, 
and Mtv-7 + homozygous B cell-mutant mice. Error bars indicate SD. In- 
crease of V314 + CD8 + T cells was 46.5% for/zMT/+  and 35.9% for 
#MT/#MT mice between the Mls-1-  and Mls-1  § genotypes (p <0.01 
and p <0.05, Student's t test). The respective  increases for V38.2 + CD8 + 
T cells were 18.3 and 19.8% ~  <0.2).  The increase in V38.2 + CD8 + 
T cells is about twofold lower than the increase of V314 § CD8 + T cells 
and is due to the deletion of Mls-reactive T cells. 
the percentage of the control V38.2 CD8 + T  cells increased 
only  slightly  (~20%)  because  of the  deletion  of the Mls- 
1-reactive V36 + ,  V37 + ,  V38.1 § ,  and  VB9 +  T  cells.  We 
could  not  detect  a  significant  difference  in  the  increase  of 
V314 +  T  cells  in  the  homo-  versus  the  heterozygous  B 
cell-deficient mice. This result indicates that B cells are not 
essential for the increase of V/~14 + T  cells in Mtv-7 + mice. 
6% 
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Figure 6.  Time  course  of  V/36  +  CD4 +  T  cell deletion  in  B 
cell-deficient mice. Spleen (solid bars) and thymus (grey bars) were removed 
from 5- and 10-d-old mice, and the percentage of V36 + CD4 + T cells 
was determined by flow cytometry. The number of mice tested is shown 
in parentheses. Day 5 animals were H-2  b and day 10 animals were H-2  b/k. 
Discussion 
Role of B  Cells  in  the  Transmission  of Infectious  MMTV. 
MMTV infects T  and B cells in the mouse (3, 38). Although 
the role of T  cells in infection has been well characterized 
(20-22), the importance of B cells was only surmised recently 
(21, 22). In this study we investigated whether mice deficient 
in B cells (24) can be infected with MMTV. For this purpose, 
B cell-deficient mice were foster nursed on MMTV-secreting 
mothers.  No  new viral DNA  in  the  spleen and  mammary 
tissue and no T  cell deletion due to MMTV  superantigens 
were detectable  in these  mice.  Furthermore,  heterozygous 
offspring of these mice showed no detectable signs of viral 
infection.  Thus,  we conclude  that  B  cells  are  essential for 
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exposed to MMTV in milk. This indicates that infection of 
T  cells is dependent on the presence of B cells,  or else we 
should have been able to detect MMTV proviruses in the 
spleens of B cell-deficient mice, which contain mainly T cells. 
The role of T  cells for the transmission  of MMTV has 
been established by several groups.  First,  Tsubura et al.  (3) 
discovered that  nude mice exposed to MMTV in milk did 
not transmit the virus to the mammary tissue, and they con- 
cluded that T cells, but not B cells, carry MMTV in the blood. 
Later,  Golovkina et al.  (20) showed that T  cells specifically 
reactive with the MMTV superantigen are required for viral 
transmission.  Namely, they demonstrated that MMTV(C3H) 
sag transgenic mice, which deleted MMTV(C3H) superan- 
tigen-reactive  V314 +  T  cells,  did  not  transmit  MMTV- 
(C3H) to their mammary tissue after exposure to this virus 
as newborns. Similar observations were made by Held et al. 
(21),  who  showed that  reconstitution  of nude  mice with 
superantigen-reactive T cells restored susceptibility to infec- 
tion. Furthermore, they found that transgenic  mice expressing 
exclusively V38.2 + TCRs, which are not reactive with the 
superantigen  of MMTV(SW),  did not  transmit  this virus 
when exposed to it in milk (22). This group also established 
that both T  and B cells can transfer MMTV in lymphocyte 
transfer experiments  (38). 
Although  our data cannot rule out that  T  cells transfer 
the virus to the mammary tissue, we think that this is un- 
likely for the following reasons.  First,  Held et al.  (21,  22) 
have shown that predominantly B cells are infected, and that 
the infection of T  cells occurs only at a later time.  Second, 
we have shown that T cells cannot be infected in the absence 
of B cells. Thus, it is conceivable that the virus is transferred 
from B cells to T cells through cell-to-cell contact, involving 
superantigen  presentation by B cells  and recognition by T 
cells. However, this leads eventually to donal deletion or anergy 
of the reactive T cells (39). Thus, the cells that are supposed 
to infect the mammary  tissue are either removed from the 
periphery or are inactivated after infection with  the virus. 
It is more likely,  therefore, that B cells transmit  MMTV 
to the mammary tissue, whereas the infected T  cells  serve 
as a storage pool for the virus.  This is consistent with the 
observation that MMTV can infect all lymphocyte subsets 
in a nonmutant mouse (38). Superantigen-reactive T cells are 
required for the stimulation of the B cells, leading to the ex- 
pansion of infected B cells (21, 22). Furthermore, this stimu- 
lation may induce expression of viral or endogenous genes 
necessary for the infection of the mammary tissue. The ob- 
servations of Tsubura and coworkers (3) can easily be explained 
with this model. In their test system, B cells did not transmit 
the virus, because nude mice were used as recipients. Thus, 
no T cells were present to stimulate the infected B cells, which 
seems to be a requirement  for the spread of the virus.  On 
the other hand,  T  cells were able to infect the nude mice, 
because the virus transferred to B cells,  and the injected T 
cells could stimulate B cells,  thus leading to viral transmis- 
sion to the mammary  tissue. 
The observation that IL-4 increases functional expression 
of superantigens  encoded by endogenous MMTV fits well 
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with  this  model  (37,  40,  41).  IL-4,  also known  as B cell 
stimulating factor 1, is secreted by activated T cells and stimu- 
lates B cells. It is reasonable to assume that infectious MMTV 
superantigen expression increases because of IL-4 stimulation, 
leading to even stronger T cell activation. On the other hand, 
we have analyzed MMTV transmission in mice deficient in 
IL-4 because of a gene-targeted disruption of the IL-4 gene 
(42),  and we could not  detect any difference between IL- 
4-deficient mice and heterozygous littermates in their ability 
to transmit MMTV or the degree of T  cell deletion due to 
infectious or endogenous MMTV  superantigens  (data not 
shown). 
Role of B Cells  for Presentation of Endogenous Superantigens. 
We also examined the role of B cells for the presentation of 
superantigens encoded by endogenous MMTVs. As a model 
we used the superantigen Mls-1, encoded by Mtv-7 sag. Al- 
though it seems clear that in vitro presentation of Mls-1 to 
T cells is restricted to B cells (23, 43, 44), it is still controver- 
sial whether B cells present Mls-1 in the thymus, thus leading 
to clonal deletion of reactive T  cells.  Several cell types have 
been suggested to induce Mls-l-driven T cell deletion in vivo. 
Inaba et al.  (45) have proposed that  CD5 + thymic B cells, 
but not splenic B cells, cause T cell deletion, whereas Mazda 
et al.  (46) detected V36 + T  cell deletion in thymic organ 
cultures only if Mls-l-expressing B cells were injected in com- 
bination with dendritic cells.  Faro et al.  (47) assumed that 
B cells exclusively present Mls-1 in the thymus. On the other 
hand, Webb and Sprent (48) showed in transfer experiments 
that CD8 + T  cells from Mls-1 + mice are the most efficient 
cell type for induction of V36 + T  cell deletion in vivo. In 
agreement with this finding, Gollob and Palmer (37, 49) ob- 
served V36 § T  cell deletion in Mls-1 § g-suppressed mice, 
which have no functional  B cells. 
Our results support the findings of the latter two groups, 
because we could find no requirement for B cells for V36 + 
T  cell deletion by Mls-1 in vivo. This does not exclude the 
possibility that  B cells are capable of inducing  T  cell dele- 
tion, but other cell types must be able to present  endoge- 
nous MMTV superantigens with similar if not even higher 
efficiency than B cells,  because no difference in the degree 
and the time course of T cell deletion was detectable between 
B cell-deficient and heterozygous control mice. We are cur- 
rently investigating which cell types actually present Mls-1 
to  the  V36 +  T  cells  in  the  B  cell-deficient  mice.  Con- 
sidering the results of Webb and Sprent (48), CD8 + T cells 
are  the most likely candidates. 
Although we obtained the same results as Gollob and Palmer 
(37, 49) regarding the deletion of Mls-l-reactive T  cells in 
g-suppressed mice, our results differ from theirs for the dele- 
tion of Mtv-9 superantigen-reactive  T  cells. No deletion of 
V35 +  CD8 +  and V311 +  CD4 + T  cells  was observed in 
g-suppressed mice; however, in B cell-deficient mice, these 
T  cells were deleted to the same degree as in normal mice. 
We have no explanation for this discrepancy, especially con- 
sidering that  the number of B220 + cells was lower in the 
B cell-deficient than  in  the #-suppressed mice. 
Still,  it could be argued that a very small and practically 
undetectable number of B cells mature in the B cell-deficient mice despite the lack of surface IgM.  These B cells would 
be sufficient to delete the Mls-l-reactive T cells, considering 
that as few as 105 B cells can induce Mls-l-driven T cell de- 
letion (38). We think that this is not the case, because we 
would expect to see a delay in the deletion kinetics or a de- 
crease in the efficiency of the deletion, both of which we did 
not observe. Furthermore, our results with MMTV-infected 
B cell-deficient mice suggest that B cells do not reach the 
periphery. Considering that MMTV-infected B cells are ex- 
panded by superantigen-specific T  cell  stimulation,  an ini- 
tially small number of B cells would be sufficient to allow 
the virus to spread in the B cells and reach the mammary 
tissue.  However, we detected no viral transmission to the 
offspring of B cell-deficient mice. 
Liao and Raulet (17)  have recently demonstrated an in- 
crease in V~14 + CD8 § T  cells in Mls-1 § H-2  k mice com- 
pared with Mls-1-  mice.  This increase was  dependent on 
the H-2 haplotype and was greater than the increase of T 
cells expressing other V/Ss, like VB8.2, which is caused by 
the deletion of Mls-l-reactive T  cells. Thus, they proposed 
that  Mls-1  positively  selects  V~14 +  CD8 +  T  cells.  We 
confirmed these results and observed that this increase  also 
occurred in the absence of B cells. This is in accordance with 
the general assumption that thymic epithelial cells, rather than 
B cells,  govern positive selection. On the other hand,  this 
would indicate that the thymic epithelium expresses Mls-1. 
Although this has been suggested before, to our knowledge 
no direct experimental evidence exists that thymic epithe- 
lium expresses Mls-1. In fact, two recent reports demonstrated 
that thymic epithelium does not express endogenous MMTV 
superantigens (50,  51). 
In this study, we have dissected the role orb lymphocytes 
in MMTV transnaission  and superantigen expression in vivo 
with B cell-deficient mice. With this experimental system, 
we have unambiguously established  that B cells are essential 
for completion of the retroviral life cycle, because no spread 
of MMTV occurred after infection in the absence of B cells. 
Because the transmission of MMTV has already been shown 
to depend on the presence of MMTV superantigen-reactive 
T  cells, we propose that B cells are necessary for infection 
of T cells, which in turn activate the infected B cells, a chain 
reaction elicited by the MMTV superantigen presented by 
the infected B cells. The superantigen presented by B cells 
is the likely candidate for an interaction molecule. On the 
other hand, we have proven that B cells are not essential for 
the presentation of superantigens encoded by endogenous 
MMTVs, because both negative and positive selection of T 
cells  due to endogenous superantigen expression occur as 
efficiently in B cell-deficient as in control mice. Thus, these 
superantigens can be presented to T cells by cell types other 
than B cells. 
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